About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Colorado | 364 Studies

Clinical Trials Prostate CancerColorado

Prostate Cancer Clinical Trials in Colorado

Find 364 clinical trials for prostate cancer near Colorado. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Colorado

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 101-120 of 364 trials

TerminatedStudy of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate CancerBone metastases and associated pain are a major cause of morbidity and mortality in castration-resistant prostate cancer (CRPC).NCT01522443·Scottsdale, Arizona and 81 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

UnknownR-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of RecurrenceRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00045123·Homewood, Alabama and 57 others

CompletedARI103094-Follow-Up Study for REDUCE Study SubjectsARI103094 is a follow-up study in adult male subjects who have received investigational product (either dutasteride or placebo) in the REDUCE Study (REduction by DUasteride of…NCT00883909·Anchorage, Alaska and 266 others

UnknownEnzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate CancerThis randomized phase III trial studies enzalutamide to see how well it works compared to enzalutamide, abiraterone, and prednisone in treating patients with castration-resistant…NCT01949337·Birmingham, Alabama and 538 others

CompletedSafety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based ChemotherapyThis is a phase 3 study to compare the clinical benefit of MDV3100 versus placebo in patients with castration-resistant prostate cancer who have been previously treated with…NCT00974311·Birmingham, Alabama and 248 others

Active not recruitingA Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).Pfizer MEVPRO-1 (C2321014) is a randomized, open-label, multi-center clinical trial evaluating whether combining the study medicine (PF-06821497) with enzalutamide is safe and…NCT06551324·Homewood, Alabama and 223 others

CompletedSafety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate CancerThe purpose of this study is to evaluate safety, tolerability and pharmacokinetics of ODM-201 in patients with castrate resistant prostate cancer.NCT01317641·Wheat Ridge, Colorado and 22 others

RecruitingA Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other TumorsThe main purpose of this study is to determine the safety, tolerability (how the body reacts to the drug\[s\]) and effectiveness (ability to treat the cancer) of REGN5678…NCT03972657·Gilbert, Arizona and 23 others

CompletedRadiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical ProstatectomyRATIONALE: Specialized radiation therapy that delivers a high-dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.NCT00528866·Phoenix, Arizona and 69 others

CompletedS1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone TherapyRATIONALE: Androgens can cause the growth of prostate cancer cells. Antiandrogen drugs, such as abiraterone acetate, may lessen the amount of androgens made by the body.NCT01309672·Jonesboro, Arkansas and 204 others

CompletedA Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active SurveillanceThe primary purpose of this study was to compare the time to prostate cancer progression (pathological or therapeutic progression) between patients treated with enzalutamide…NCT02799745·Birmingham, Alabama and 53 others

CompletedPROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyPROSTVAC-VF is an investigational cancer vaccine.NCT00078585·Homewood, Alabama and 46 others

CompletedA Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate CancerThe purpose of this study is to determine the benefit of enzalutamide versus placebo as assessed by overall survival and progression-free survival in patients with progressive…NCT01212991·Birmingham, Alabama and 268 others

TerminatedStudy to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid TumorsThe goal of this interventional clinical trial is to learn about TNG348, a ubiquitin specific peptidase 1 (USP1) inhibitor, alone and in combination with olaparib in patients with…NCT06065059·Denver, Colorado and 6 others

CompletedS9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate CancerRATIONALE: Hormones can stimulate the production of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens.NCT00004124·Anchorage, Alaska and 233 others

CompletedStudy of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)The purpose of this study is to assess the efficacy and safety of the combination of pembrolizumab (MK-3475) and docetaxel in the treatment of men with metastatic…NCT03834506·Mobile, Alabama and 214 others

CompletedStudy of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate CancerThe primary objective of this study was to compare the two alternate primary endpoints of radiographic progression-free survival (rPFS) and overall survival (OS) in patients with…NCT03511664·Scottsdale, Arizona and 87 others

CompletedRadiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective for bone metastases.NCT00003162·Birmingham, Alabama and 252 others

CompletedRadiation Therapy in Treating Patients With Stage II Prostate CancerRATIONALE: Giving radiation therapy that uses a 3-dimensional (3-D) image of the tumor to help focus thin beams of radiation directly on the tumor, and giving hypofractionated…NCT00331773·Phoenix, Arizona and 295 others

UnknownMulti-Institutional Registry for Prostate Cancer RadiosurgeryTo address pertinent questions regarding the utilization of stereotactic Body Radiotherapy (SBRT) to treat prostate cancer.NCT01226004·Birmingham, Alabama and 43 others

PreviousPage 6 of 19Next

Other Conditions in Colorado

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma